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Abstract: Signal transducers and activators of
transcription (STATs) are crucial molecules in cy-
tokine signaling. In the conventional model of
STAT activation, STAT molecules are recruited
from a latent pool of cytoplasmic monomers to the
activated cytokine receptor. After binding to the
receptor, they get tyrosine-phosphorylated, disso-
ciate from the receptor, and translocate to the
nucleus as activation-induced dimers. Recently,
several publications questioned this model of STAT
activation and showed the existence of preassoci-
ated STAT molecules before activation. We were
able to demonstrate the existence of these preas-
sociated STAT3 molecules in living mammalian
cells using bioluminescence resonance energy
transfer. Our results support the new hypothesis
that STAT molecules exist in the cytoplasm as
dimers or multimers and point to an activation-
induced change in STAT3 conformation. There-
fore, we propose a new model of STAT activation
and discuss a hypothetical structure of “cytoplas-
mic” STAT dimers as opposed to the known “acti-
vation-induced” dimer. J. Leukoc. Biol. 75:
792–797; 2004.
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INTRODUCTION
Cytokines are crucial molecules for orchestrating the host
response against invading pathogens, and signal transducers
and activators of transcription (STATs) play a central role in
the signaling pathways activated by cytokine receptors. The
model of STAT activation says that cytokine binding to their
receptors leads to receptor aggregation and phosphorylation of
specific tyrosine residues by Janus kinases (Jaks). Subse-
quently, STAT molecules bind to their phosphorylated recep-
tor-docking sites with their Src homology (SH)2 domains and
get tyrosine-phosphorylated by the Jaks. The STATs then dis-
sociate from the receptor and dimerize by means of the SH2
domain, binding to the phosphorylated tyrosine residues of
another STAT monomer. Afterwards, they translocate to the
nucleus and induce the expression of target genes. This widely
recognized model of STAT activation is based on the hypoth-
esis that STAT molecules are recruited from a monomeric pool
in the cytoplasm and dimerize only after activation-induced
phosphorylation [1, 2]. However, some publications have re-
cently suggested the existence of STAT dimers before activa-
tion, and Ndubuisi et al. [3] have even proposed the existence
of a multimeric “statosome” in which STATs are associated not
only with each other but also with additional chaperone pro-
teins [4–6]. Nevertheless, the structure and function of the
putative cytoplasmic dimers or multimers are largely unknown.
It is very likely that they differ from the activation-induced
nuclear dimers, which form via the SH2 domains and the
phosphorylated tyrosine residues, both located close to the
C-terminus. The structure of the STAT3 dimer binding to the
DNA has been solved and shows a pliers-like structure with the
C-termini on top of the DNA strand and the N-termini stretch-
ing apart at either side of the strand [7].
It has been described that not only the SH2 domain but also
the N-terminal domain of the STATs are required for receptor
binding [8, 9], and very recently Zhang et al. [10] proposed an
intramolecular interaction between the C- and the N-terminal
domains of STATs, which is necessary for receptor binding.
These observations queried the conventional model of STAT
activation and evoked the need for further investigations.
Bioluminescence resonance energy transfer (BRET) is a
recently developed method to investigate protein–protein in-
teractions in living mammalian cells. BRET takes advantage of
a natural phenomenon, namely the Fo¨rster energy transfer
between a light-emitting luciferase and an acceptor fluoro-
phore. A bioluminescent luciferase [Renilla luciferase (Rluc)]
is fused to one of the proteins of interest and a green fluores-
cent protein [enhanced yellow fluorescent protein (EYFP)] to
the other. In the presence of its substrate, Rluc emits light
(max 480 nm), which excites the acceptor fluorophore EYFP,
if the two molecules are close enough for energy transfer to
occur. It is important to note that those do not naturally
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associate with each other [11]. An interaction between the two
fusion proteins should bring the luciferase and EYFP close
enough for energy transfer to occur. By means of this method,
protein interactions can be detected in living cells and be
followed over a time-course or under varying conditions. BRET
has been successfully used to investigate membrane receptor
dimerization and has proven its suitability to detect existing
protein interactions [12–14].
We used the BRET assay to investigate the association of
STAT3 molecules before and after activation. For the first time,
we detected an interaction of nonphosphorylated STAT mole-
cules in living cells. Furthermore, our experiments may allow
some conclusions about the structure of the cytoplasmic-pre-
associated STAT molecules, suggesting a reorganization of the
STAT dimers after activation.
MATERIALS AND METHODS
Cell culture
COS-1 cells were maintained in Dulbecco’s modified Eagle’s medium plus
10% fetal calf serum, L-glutamine, and penicillin/streptomycin. One day
before transfection, cells were plated at a density of 5  105 cells per 5 cm
dish.
Plasmid construction
The BRET expression vectors are based on the pcDNA3.1 vector containing
the open reading frame for EYFP or for Rluc [14]. We inserted the complete
coding sequences of STAT3 or STAT6 in a way that led to the expression of
N-terminal or C-terminal fusion proteins with EYFP or Rluc. The inserts were
generated by polymerase chain reaction amplification from IMAGE_3347434
clone (STAT3) or IMAGE_2958389 clone (STAT6; rzpd, Berlin, Germany)
using mutagenic primers introducing the appropriate restriction sites.
Western blotting
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot-
ting were performed using standard procedures. The phosphorylated form of
the STAT3 fusion protein was detected with phospho-specific antibodies
against STAT3–Tyr705 (Cell Signaling Technology, Beverly, MA).
BRET assay
COS-1 cells were transfected with the Rluc–STAT3 protein alone or in
combination with EYFP or the STAT3–EYFP fusion protein. Transfections
were performed using the Superfect reagent (Qiagen, Valencia, CA) according
to the manufacturer’s recommendations. Total plasmid DNA (3 g) was used
for transfection, and the empty vector was used to equalize DNA amounts in
each sample. After 48 h, cells were harvested, washed twice with phosphate-
buffered saline, and used for BRET analysis. Flow cytometric analysis was
performed to check for comparable EYFP expression of EYFP and the EYFP–
STAT3 fusion protein.
Approximately 50,000 cells/well were distributed in a 96-well plate, the
cell-permeable Rluc substrate coelenterazine (h form; Molecular Probes, Eu-
gene, OR) was added to a final concentration of 5 M, and readings were
collected immediately following this addition. Repeated readings were taken
for at least 5–10 min using a custom-designed BRET instrument (Berthold,
Australia), which allows for sequential integration of the signals detected in the
440–500 and 510–590 nm windows. Human recombinant epidermal growth
factor (EGF; Promega, Annandale, Australia) was added to a concentration of
100 ng/ml to activate STAT3, and readings were collected for another 10–20
min afterwards. Data were analyzed as a normalized BRET ratio, which is
defined as the BRET ratio for the coexpression of the Rluc and EYFP
constructs normalized against the BRET ratio for the Rluc expression construct
alone.
To quantify the BRET signal generated, the ratio of the light emitted by the
EYFP fusion protein (510–590 nm) over that emitted by the Rluc fusion
protein (440–500 nm) was determined by using the following equation [12]:
[(emission at 510–590 nm)–(emission at 440–500 nm)cf]/(emission at 440–
500 nm). cf corresponds to (emission at 510–590 nm/emission at 440–500 nm)
for the Rluc construct expressed alone in the same experiment.
RESULTS
To use the BRET assay for investigating homophilic interac-
tions of STAT molecules, we made fusion proteins with Rluc or
EYFP fused to the C-terminus of STAT3 (STAT3–Rluc and
STAT3–EYFP). As the STAT3 molecule is relatively large and
spans 110 Å [7], and the critical Fo¨rster radius for energy
transfer is 50 Å [15], we also fused Rluc N-terminally to the
STAT3 molecule (Rluc–STAT3). Thereby, we hoped to detect
interactions independent of the orientation of the STAT3 mol-
ecules in the dimer/multimer.
EGF rapidly phosphorylates the STAT3–Rluc
fusion protein
We aimed at investigating the interaction between STAT3
molecules in the nonactivated state as well as after tyrosine
phosphorylation. It has been reported previously that EGF is
able to efficiently induce tyrosine phosphorylation of trans-
fected STAT3 in COS-1 cells [9]. These cells also have re-
ported low levels of endogenous STAT molecules, which is
additionally convenient for our analysis, as high levels of
endogenous STAT3 might lower the obtained energy transfer
signal by forming dimers with fusion proteins, sequestering
them in non-BRETting complexes. When we stimulated our
transfected COS-1 cells with 100 ng/ml recombinant human
EGF we were able to induce a strong, rapid, and lasting
tyrosine phosphorylation of the STAT3–Rluc fusion protein,
which we detected by Western blotting with phospho-specific
antibodies against Tyr705 of STAT3 (Fig. 1).
STAT3 molecules are preassociated in living
COS-1 cells
For the BRET assay, COS-1 cells transfected with STAT3–
Rluc and STAT3–EYFP or Rluc–STAT3 and STAT3–EYFP
were incubated with the luciferase substrate coelenterazine,
and light-emission acquisition was performed immediately.
The energy transfer was quantified using the equation [12]
described in Materials and Methods. Basically, the difference
Fig. 1. COS-1 cells transfected with STAT3–Rluc were stimulated for the
time periods indicated with 100 ng/ml human recombinant EGF. Cells were
then lysed and subjected to Western blot analysis. Phosphorylated fusion
protein was detected with a phospho-specific antibody for STAT3 and identi-
fied by its molecular weight.
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between the BRET ratio for the Rluc construct alone and the
BRET ratio for cells expressing the Rluc and the EYFP fusion
protein was used as a measure for the occurring energy transfer
and normalized to Rluc expression (normalized BRET ratio).
Energy transfer was detected before activation with EGF be-
tween STAT3–Rluc and STAT3–EYFP (Fig. 2A) as well as
Rluc–STAT3 and STAT3–EYFP (Fig. 2B). The detected signal
was similar for both combinations and very stable and repro-
ducible. A preactivation of these cells was ruled out by West-
ern blotting (Fig. 1) with a phospho-specific antibody for
STAT3. There was no phosphorylated STAT3 detectable in the
cells before activation with EGF, which was also followed over
a time-course of 30 min (data not shown). As a control, we
overexpressed EYFP at a similar level to the fusion protein
(controlled by flow cytometry analysis) together with either of
the STAT3 luciferase constructs. There was no BRET signal
detectable in this control, not even when EYFP was expressed
at a much higher level. Therefore, the observed energy transfer
between the STAT3 fusion proteins was not a result of a vast
overexpression of EYFP in the cells. Furthermore as another
control, no energy transfer occurred between STAT3–Rluc and
a STAT6–EYFP construct, which points toward a specific
interaction between the STAT3 fusion molecules.
What happens to the BRET signal after
activation?
Next, we wondered whether the signal obtained for the energy
transfer between the STAT3 fusion proteins would change in
any way after activation-induced phosphorylation by EGF
treatment. As one of the advantages of the BRET technology,
we were able to follow the same cells before and after activa-
tion. To this end, we used the same experimental procedure as
described above. After the collection of 10 readings, we added
EGF to a final concentration of 100 ng/ml and continued to
collect data for another 15–20 min.
For the combination of the two C-terminal constructs
(STAT3–Rluc and STAT3–EYFP) the signal remained un-
changed after addition of EGF (Fig. 3A).
However, when we used the N-terminal luciferase construct
(Rluc–STAT3) in combination with the C-terminal fusion pro-
tein STAT3–EYFP, energy transfer occurring between Rluc–
STAT3 and STAT3–EYFP rather seemed to decrease after
activation with EGF (Fig. 3B). This unexpected finding might
be explained by a qualitative difference in the “cytoplasmic
dimmer” and the activation-induced “nuclear dimmer” as dis-
cussed further below.
DISCUSSION
With the BRET assay, we were able to detect the existence of
associated STAT3 molecules before activation and tyrosine-
phosphorylation in living mammalian cells. The BRET assay is
based on the overexpression of fusion proteins, and therefore,
higher than physiologic concentrations of STAT molecules are
present in the cells and might influence their interaction be-
havior. Nevertheless, BRET as well as the related fluorescence
RET (FRET) technique have been used for a variety of studies
and have proven their suitability to detect real protein inter-
actions [16]. We modestly overexpressed our fusion proteins
and included the necessary controls so that our results are
unlikely to be mere overexpression artifacts. Furthermore,
Haan et al. [5] and Novak et al. [4] have shown the existence
of preassociated STAT molecules by immunoprecipitation
studies. We believe that our results are important in that they
support these findings and uniquely demonstrate the occur-
rence of these STAT associates in living mammalian cells.
Although we continue to refer to these associates as dimers, we
do not exclude the existence of higher-order complexes, as has
been suggested by Ndubuisi et al. [3], as the BRET assay
cannot differentiate between dimers and higher-order multim-
ers. The actual composition of these cytoplasmic associates
should be the target of further investigations.
There are also at least two reports in the literature, which
would suggest that STATs bind to the activated cytokine re-
ceptors in a dimeric rather than the monomeric form suggested
Fig. 2. (A) The C-terminal fusion protein STAT3–Rluc (0.5 g) was transfected alone or in combination with the C-terminal fusion protein STAT3–EYFP (2 g),
EYFP (1 g), or STAT6–EYFP (2 g) into COS-1 cells. Cells were harvested 48 h post-transfection, and the BRET assay was performed at 37°C. Ten repetitive
readings were collected, and an average of the normalized BRET ratio is depicted in this diagram. Shown is one representative experiment out of four. (B) The
N-terminal fusion protein Rluc–STAT3 (1.5 g) was transfected alone or with the above-mentioned constructs into COS-1 cells. The assay was performed as
described above.
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by the current model of STAT activation. Behrmann et al. [17]
demonstrated that a single STAT-binding site in a chimeric
receptor complex is sufficient to activate STATs. In a very
interesting study, the group of Sidney Pestka [18] used the
FRET technique to demonstrate that interferon receptors are
preassembled on the cell surface and that their intracellular
domains move apart upon ligand binding. This might allow for
the binding of a STAT dimer in the groove between the two
receptor chains. We included this hypothesis into the new
model of STAT activation that we suggest below.
We made the surprising observation that the BRET signal
decreased after activation when Rluc was fused to the N-
terminus of one, and EYFP was fused to the C-terminus of the
other STAT3 molecule. This decrease was not observed when
EYFP and Rluc were fused to the respective C-termini. We
cannot exclude that this different behavior is simply caused by
different properties of the luciferase constructs, such as a
decreased stability of the Rluc–STAT3 protein. Furthermore,
RET is not only dependent on the distance between the two
fusion proteins but also on their proper orientation to each
other. It is therefore thinkable that binding to the DNA or
interaction with other proteins influences the orientation of the
tag in the N-terminal but not the C-terminal fusion protein and
reduces the ability of the former to elicit energy transfer.
Keeping these reservations in mind, we wondered whether
our observation could also be explained by assuming qualita-
tive differences between the cytoplasmic STAT3 associates
(before activation) and the nuclear STAT3 dimer, which forms
after activation.
From the crystal structure of the nuclear STAT3 dimer, it
has been determined that the C-termini are very close together,
the N-termini stretch apart, and each N-terminal domain alone
spans 80 Å [7]. Therefore, it would be plausible and in
accordance with our results, that BRET occurs more efficiently
when both tags are fused to the C-termini than when one is
fused to the C-terminus and one to the N-terminus (Fig. 4).
On this assumption, the BRET experiments indicate a dif-
ferent orientation of the terminal domains in the cytoplasmic
associates. The BRET signal decreased after activation, which
points to a smaller distance between the C-terminus of one and
the N-terminus of the other monomer in the cytoplasmic asso-
ciates than in the nuclear dimer. In contrast, the C-termini
should be close to each other also in the cytoplasmic associ-
ates, as no change in the BRET signal was detected after
activation when the two C-terminal fusion proteins were used
for the BRET assay. The finding of Novak et al. [4], who
demonstrated that the formation of the nonactivated STAT3
associates was dependent on the C-terminal domain but inde-
pendent of the SH2 domain, might support this.
A recent publication by Zhang et al. [10] showed an inter-
action between the N-terminal and the C-terminal domain of
STAT3, which was necessary for receptor binding. The authors
suggested that this is an intramolecular association between
these two domains, which renders the SH2 domain accessible
for binding to the receptor. Nevertheless, they cannot exclude
that this binding property is also part of an intermolecular
association between the STAT3 monomers, which would be
favored by our results. Another possibility would be that the
intramolecular interaction proposed by Zhang et al. [10] leads
to a condensed structure of the STAT3 associates, which brings
the C-termini and the N-termini into the close proximity nec-
essary for efficient energy transfer.
Based on our data and the findings of Krause et al. [18],
Zhang et al. [10], and Novak et al. [4], we suggest a new model
of STAT activation, which comprises a latent cytoplasmic
dimer and the known activation-induced nuclear dimer (Fig.
5). Activation-induced phosphorylation of the STATs renders
the cytoplasmic dimer unstable and leads to a reorganization
Fig. 3. (A) The C-terminal fusion protein STAT3–Rluc (0.5 g) was trans-
fected alone or in combination with the C-terminal fusion protein STAT3–
EYFP (2 g) into COS-1 cells. Cells were harvested 48 h post-transfection,
EYFP expression was checked by flow cytometry, and the BRET assay was
performed at 37°C. Ten repetitive readings were collected (approximately 10
min) before addition of EGF. Cells were then incubated for 5 min at 37°C to
achieve tyrosine phosphorylation of STAT3, before 15 more readings were
collected. The column diagram depicts the normalized BRET ratios before
(gray column) and after addition of EGF (black column). (B) The N-terminal
fusion protein Rluc–STAT3 (1.5 g) was transfected alone or with the above-
mentioned constructs into COS-1 cells. The assay was performed as described
above.
Fig. 4. Schematic drawing of the nuclear STAT3 dimer, indicating the
positions of EYFP and Rluc, respectively. (A) EYFP and Rluc are fused to the
C-termini (C) of the respective STAT3 monomers. The C-termini are close to
each other, and therefore, BRET might occur very efficiently from Rluc to
EYFP. (B) Rluc is fused to the N-terminus of one STAT3 monomer and EYFP
to the C-terminus of the other STAT3 monomer. As the N-terminus (N) is very
elongated in the nuclear dimer, Rluc and EYFP are relatively distant, and
therefore, BRET might occur less efficiently than in A.
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resulting in the formation of the known nuclear dimer. We are
aware that this model is highly speculative, but we believe that
it could provide a platform for discussion and further research.
The conventional model of STAT activation did not provide a
satisfying explanation for the dissociation of the STAT mole-
cules from the receptor and for their nuclear transport. It is
highly unlikely that a nuclear localization signal is revealed by
a dimerization event. The new model might explicate this
process more feasibly. Tyrosine phosphorylation of the STAT
molecule has been shown to disturb the intramolecular inter-
action necessary for receptor binding and is therefore likely to
provoke dissociation from the receptor. This structural change
then probably leads to the formation of the known activation-
induced STAT dimer, which is associated via the phosphory-
lated tyrosine residue and the SH2 domain of the second STAT
molecule. It is rather conceivable that this structural change
might display a nuclear localization signal, which can be
recognized by importin molecules, and leads to the selective
nuclear import of the activation-induced STAT dimers.
We hope that our alternate hypothesis (Fig. 5) leads to a
reconsideration of STAT activation and reanimates research in
this area.
Further investigation of the structure and function of the
proposed cytoplasmic STAT dimers is necessary. An interest-
ing, open question is whether the cytoplasmic STAT molecules
actually form dimers or higher-order complexes and whether
they only form homogeneous or also heterogeneous complexes
with other STAT molecules or other signaling or chaperone
proteins. Processes such as receptor-binding and dimerization
as well as nuclear translocation of STAT molecules might be
strongly connected to the structural change implicated by our
model, and its investigation might lead to a better understand-
ing of cytokine signaling.
NOTE
While this paper was in proof, the group of K. Murphy pub-
lished a study showing that association of nonphosphorylated
STAT4 molecules also occurs and is even necessary for acti-
vation of STAT4. The N-terminal domain of STAT4 was crucial
for this interaction to occur [19]. Also during the preparation of
this paper, Kretzschmar et al. published very similar results to
ours for murine Stat3 using fluorescence resonance energy
transfer. Interestingly they found that the SH2 domain of Stat3
was essential for formation of the preassociated dimers [20].
ACKNOWLEDGMENTS
This work was partially supported by the SFB421 (G. G. and
H-D. V.). We thank the Boehringer Ingelheim Fonds for finan-
cially supporting the stay of M. S. at the Western Australian
Institute for Medical Research.
REFERENCES
1. Leonard, W. J., O’Shea, J. J. (1998) Jaks and STATs: biological implica-
tions. Annu. Rev. Immunol. 16, 293–322.
2. Imada, K., Leonard, W. J. (2000) The Jak-STAT pathway. Mol. Immunol.
37, 1–11.
Fig. 5. A new model of STAT activation. This simplified sche-
matic drawing shows the intramolecular interaction between the C-
and the N-terminus (C and N, respectively) of STAT3, which was
proposed by Zhang et al. [10] and suggests a model of receptor-
binding of the hypothetical, cytoplasmic STAT dimer. In this
dimer, the STAT monomers associate via their C-termini, and the
intramolecular interaction between the C-terminus and the N-
terminus of one STAT monomer renders the SH2 domain accessi-
ble for receptor-binding. After tyrosine phosphorylation, a confor-
mational change occurs, which leads to the formation of the known
activation-induced STAT dimers. Jak1, Janus kinase 1; Tyk2,
tyrosine kinase 2; Y-P and P-Y, phosphorylated tyrosine residues;
SH2, src-homology domain 2; C, C-terminus; N, N-terminus.
796 Journal of Leukocyte Biology Volume 75, May 2004 http://www.jleukbio.org
3. Ndubuisi, M. I., Guo, G. G., Fried, V. A., Etlinger, J. D., Sehgal, P. B.
(1999) Cellular physiology of STAT3: where’s the cytoplasmic monomer?
J. Biol. Chem. 274, 25499–25509.
4. Novak, U., Ji, H., Kanagasundaram, V., Simpson, R., Paradiso, L. (1998)
STAT3 forms stable homodimers in the presence of divalent cations prior
to activation. Biochem. Biophys. Res. Commun. 247, 558–563.
5. Haan, S., Kortylewski, M., Behrmann, I., Muller-Esterl, W., Heinrich,
P. C., Schaper, F. (2000) Cytoplasmic STAT proteins associate prior to
activation. Biochem. J. 345, 417–421.
6. Stancato, L. F., David, M., Carter-Su, C., Larner, A. C., Pratt, W. B. (1996)
Preassociation of STAT1 with STAT2 and STAT3 in separate signalling
complexes prior to cytokine stimulation. J. Biol. Chem. 271, 4134–4137.
7. Becker, S., Groner, B., Muller, C. W. (1998) Three-dimensional structure
of the Stat3 homodimer bound to DNA. Nature 394, 145–151.
8. Murphy, T. L., Geissal, E. D., Farrar, J. D., Murphy, K. M. (2000) Role of
the Stat4 N domain in receptor proximal tyrosine phosphorylation. Mol.
Cell. Biol. 20, 7121–7131.
9. Zhang, T., Kee, W. H., Seow, K. T., Fung, W., Cao, X. (2000) The
coiled-coil domain of Stat3 is essential for its SH2 domain-mediated
receptor binding and subsequent activation induced by epidermal growth
factor and interleukin-6. Mol. Cell. Biol. 20, 7132–7139.
10. Zhang, T., Seow, K. T., Ong, C. T., Cao, X. (2002) Interdomain interaction
of Stat3 regulates its Src homology 2 domain-mediated receptor binding
activity. J. Biol. Chem. 277, 17556–17563.
11. Xu, Y., Piston, D. W., Johnson, C. H. (1999) A bioluminescence reso-
nance energy transfer (BRET) system: application to interacting circadian
clock proteins. Proc. Natl. Acad. Sci. USA 96, 151–156.
12. Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M.,
Bouvier, M. (2000) Detection of 2-adrenergic receptor dimerization in
living cells using bioluminescence resonance energy transfer (BRET).
Proc. Natl. Acad. Sci. USA 97, 3684–3689.
13. Angers, S., Salahpour, A., Bouvier, M. (2001) Biochemical and biophys-
ical demonstration of GPCR oligomerization in mammalian cells. Life Sci.
68, 2243–2250.
14. Kroeger, K. M., Hanyaloglu, A. C., Seeber, R. M., Miles, L. E., Eidne,
K. A. (2001) Constitutive and agonist-dependent homo-oligomerization of
the thyrotropin-releasing hormone receptor. Detection in living cells using
bioluminescence resonance energy transfer. J. Biol. Chem. 276, 12736–
12743.
15. Mahajan, N. P., Linder, K., Berry, G., Gordon, G. W., Heim, R., Herman,
B. (1998) Bcl-2 and Bax interactions in mitochondria probed with green
fluorescent protein and fluorescence resonance energy transfer. Nat. Bio-
technol. 16, 547–552.
16. Mercier, J. F., Salahpour, A., Angers, S., Breit, A., Bouvier, M. (2002)
Quantitative assessment of 1- and 2-adrenergic receptor homo- and
heterodimerization by bioluminescence resonance energy transfer. J. Biol.
Chem. 277, 44925–44931.
17. Behrmann, I., Janzen, C., Gerhartz, C., Schmitz-Van de Leur, H., Her-
manns, H., Heesel, B., Graeve, L., Horn, F., Tavernier, J., Heinrich, P. C.
(1997) A single STAT recruitment module in a chimeric cytokine receptor
complex is sufficient for STAT activation. J. Biol. Chem. 272, 5269–
5274.
18. Krause, C. D., Mei, E., Xie, J., Jia, Y., Bopp, M. A., Hochstrasser, R. M.,
Pestka, S. (2002) Seeing the light: preassembly and ligand-induced
changes of the interferon  receptor complex in cells. Mol. Cell. Proteom-
ics 1, 805–815.
19. Ota, N., Brett, T. J., Murphy, T. L., Fremont, D. H., Murphy, K. M. (2004)
N-domain-dependent nonphosphorylated STAT4 dimers required for cy-
tokine-driven activation. Nat. Immunol. 5, 208–215.
20. Kretzschmar, A. K., Dinger, M. C., Henze, C., Brocke-Heidrich, K., Horn
F. (2004) Analysis of Stat3 (signal transducer and activator of transcription
3) dimerization by fluorescence resonance energy transfer in living cells.
Biochem J. 377(Pt. 2), 289–297.
Schro¨der et al. STAT3 associates prior to activation in living cells 797
